Department of Ophthalmology, College of Medicine, University of Ibadan.
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences. Queens University, Belfast, UK.
J Glaucoma. 2024 Dec 1;33(12):951-956. doi: 10.1097/IJG.0000000000002487. Epub 2024 Aug 15.
Patients' acceptance of glaucoma therapy was high overall in this study, but lower for surgery than for laser or medical therapy. Fear and cost were the leading reasons why patients declined recommended therapy and they were treatment-specific. Cost was the primary reason for declining medical and laser therapy, while fear was the most common reason for declining surgical therapy.
To determine the frequency at which patients newly diagnosed with glaucoma in sub-Saharan Africa (SSA) decline recommended therapy and to characterize the reasons for declining therapy.
This was a multicenter, cross-sectional study conducted on adult patients at the time of glaucoma diagnosis at 27 centers in 10 countries in SSA. Data collected from the diagnostic encounter included demographics, clinical glaucoma characteristics, treatment recommendations, patient acceptance of therapy, and reasons for declining therapy.
Among 2282 eyes of 1198 patients offered treatment for glaucoma, initially recommended treatment was accepted in 2126 eyes (93.2%). Acceptance of therapy varied with the nature of treatment offered, with medical therapy accepted in 99.2% of eyes, laser therapy in 88.3%, and surgical therapy in 69.3%. The most common reasons cited for declining therapy were fear (42.9%) and cost (41.7%); cost was the primary reason for declining medical and laser therapy, while fear was the most common reason for declining surgical therapy. Most patients declining laser or surgical therapy accepted medical therapy as an alternate therapy (98.1%).
Patients' acceptance of glaucoma therapy was high overall, but lower for surgery than for laser or medical therapy. Most patients who declined laser or surgical therapy accepted medical therapy as an alternate therapy when offered. Educational interventions, sustainable incentives, and other approaches are needed to enhance patient acceptance of glaucoma therapy in this setting, particularly surgery, when needed.
在这项研究中,总体而言,患者对青光眼治疗的接受度很高,但手术治疗的接受度低于激光或药物治疗。患者拒绝推荐治疗的主要原因是恐惧和费用,且这些原因因治疗方式而异。费用是拒绝药物和激光治疗的主要原因,而恐惧是拒绝手术治疗的最常见原因。
确定撒哈拉以南非洲(SSA)新诊断为青光眼的患者拒绝推荐治疗的频率,并描述拒绝治疗的原因。
这是一项多中心、横断面研究,在 SSA 10 个国家的 27 个中心,在青光眼诊断时对成年患者进行。从诊断性就诊中收集的数据包括人口统计学、临床青光眼特征、治疗建议、患者对治疗的接受程度以及拒绝治疗的原因。
在 2282 只眼的 1198 例患者中,最初推荐的治疗方案中有 2126 只眼(93.2%)被接受。治疗方案的接受程度因所提供治疗方案的性质而异,药物治疗的接受率为 99.2%,激光治疗为 88.3%,手术治疗为 69.3%。拒绝治疗最常见的原因是恐惧(42.9%)和费用(41.7%);费用是拒绝药物和激光治疗的主要原因,而恐惧是拒绝手术治疗的最常见原因。大多数拒绝激光或手术治疗的患者接受了药物治疗作为替代治疗(98.1%)。
总体而言,患者对青光眼治疗的接受度较高,但手术治疗的接受度低于激光或药物治疗。大多数拒绝激光或手术治疗的患者在被提供药物治疗时会接受这种替代治疗。在这种情况下,需要进行教育干预、可持续激励和其他方法来提高患者对青光眼治疗的接受度,特别是在需要手术治疗时。